Missouri Senate Bill SB1580

Missouri 2026 Regular Session

• Introduced: 1/20/26
• Refer: 2/5/26

Caption

Modifies provisions relating to ketamine

Impact

If SB1580 is enacted, it will modify existing laws related to the prescription and administration of controlled substances, particularly focusing on ketamine. The legislation will delineate clear responsibilities and protocols for healthcare providers, particularly physicians and advanced practice registered nurses. This change is aimed at ensuring that there are strict guidelines about who prescribes and administers ketamine, thus potentially lowering the risks associated with its misuse. The increased supervision and requirement for a documented treatment plan could also improve patient outcomes for those seeking mental health treatment using ketamine, reflecting a shift towards more structured mental health care protocols.

Summary

Senate Bill 1580 focuses on the regulation of ketamine administration for mental health purposes in Missouri. The bill seeks to repeal the current provisions governing the use of ketamine and replace them with new regulations designed to enhance patient safety and ensure proper oversight in the administration of this controlled substance. Under the proposed legislation, only licensed physicians will have the authority to delegate the administration of ketamine and will need to maintain close supervision during its administration. This specific oversight is intended to safeguard patients undergoing treatment, ensuring that trained professionals are present at all times.

Contention

There may be points of contention surrounding the bill's implications for practice autonomy among healthcare providers. Some advocates for healthcare providers may express concerns that the increased regulatory framework could impose burdens on practitioners, particularly advanced practice registered nurses, who previously had more leeway in prescribing treatments. Further, the debate may center around the accessibility of ketamine treatment for patients suffering from mental health issues, with some arguing that stringent regulations might restrict the availability of this therapeutic option to those in need.